Fresh on the heels of the NutraIngredients Weight Management Summit, it’s time to check in on the rapidly evolving landscape of GLP-1 receptor agonists and their implications for the food industry.

What We Know

All signs indicate that GLP-1 receptor agonists are here to stay. With 16 million Americans currently using these drugs—and 40% taking them purely for weight loss—adoption is widespread. Consumer awareness of GLP-1 medications is remarkably high, and satisfaction rates among users are equally impressive. The expected introduction of oral pill formats will likely drive even greater expansion in use.

Who Are GLP-1 Receptor Agonist Users?

GLP-1 RA users seeking weight loss generally fall into two categories:

1.Long-term users: Individuals with a history of obesity who will likely remain on these medications for the foreseeable future.

2.Short-term users: Those with relatively less weight to lose (20 lbs or less). This group tends to be highly motivated and is more likely to discontinue the medication after achieving their weight loss goals.

How Can the Food Industry Support These Consumers?

The food and ingredient industry must anticipate significant shifts in consumer behavior, particularly as reduced food intake leads to changes in spending habits. Certain food categories—such as high-calorie snacks and indulgent foods—may see declines, while demand may rise for functional foods that support satiety, muscle maintenance, and metabolic health.

Notably, 50% of GLP-1 RA users report receiving no guidance on adjusting their lifestyle while on the medication. This presents a major opportunity for the food industry to step in and fill the gap. Data suggests that GLP-1 RA users are highly receptive to tailored products designed to support what’s often called the “GLP-1 lifestyle.” Key areas of opportunity include:

·    Foods that accelerate weight loss by complementing the effects of GLP-1 medications.

·    Products to manage side effects, such as nausea-friendly formulations or gut health solutions.

·    High-protein options to counteract muscle loss, a key concern with rapid weight loss.

·    Sustainable nutrition strategies for maintaining weight after discontinuing medication.

As GLP-1 RA use continues to grow, food and nutrition brands have a unique opportunity to innovate and meet evolving consumer needs. Early and strategic action will set food and ingredient companies up for success in this rapidly changing environment.